High prevalence of metabolic obesity in India: The ICMR-INDIAB national study (ICMR-INDIAB-23).

IF 2.5 4区 医学 Q3 IMMUNOLOGY
Deepa Mohan, Rajendra Pradeepa, Ulagamadesan Venkatesan, Prabha Adhikari, Hiranya Kumar Das, Kalpana Dash, Jatinder Kumar Mokta, Somorjit Ningomban, Rosang Luaia, Richard O Budnah, Anil Bhansali, Lobsang Jampa, Vizolie Suokhrie, Sunil M Jain, Prashant P Joshi, Shashank Joshi, Anil J Purty, Karma Jigme Tobgay, Taranga Reang, Sri Venkata Madhu, Elangovan Nirmal, Radhakrishnan Subashini, Sudha Vasudevan, Arumugam Muruganathan, Krishna G Seshadri, Ranjit Unnikrishnan, Ashok Kumar Das, Tanvir Kaur, Rupinder Singh Dhaliwal, Viswanathan Mohan, Ranjit Mohan Anjana
{"title":"High prevalence of metabolic obesity in India: The ICMR-INDIAB national study (ICMR-INDIAB-23).","authors":"Deepa Mohan, Rajendra Pradeepa, Ulagamadesan Venkatesan, Prabha Adhikari, Hiranya Kumar Das, Kalpana Dash, Jatinder Kumar Mokta, Somorjit Ningomban, Rosang Luaia, Richard O Budnah, Anil Bhansali, Lobsang Jampa, Vizolie Suokhrie, Sunil M Jain, Prashant P Joshi, Shashank Joshi, Anil J Purty, Karma Jigme Tobgay, Taranga Reang, Sri Venkata Madhu, Elangovan Nirmal, Radhakrishnan Subashini, Sudha Vasudevan, Arumugam Muruganathan, Krishna G Seshadri, Ranjit Unnikrishnan, Ashok Kumar Das, Tanvir Kaur, Rupinder Singh Dhaliwal, Viswanathan Mohan, Ranjit Mohan Anjana","doi":"10.25259/IJMR_328_2025","DOIUrl":null,"url":null,"abstract":"<p><p>Background & objectives While obesity usually produces cardio-metabolic dysfunction, some obese individuals are metabolically healthy, and conversely, some nonobese individuals have significant metabolic dysfunction. This study aims to assess the national prevalence of various obesity subtypes and their association with type 2 diabetes (T2D), coronary artery disease (CAD), and chronic kidney disease (CKD) in the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Methods The ICMR-INDIAB study is a nationally representative cross-sectional survey of 1,13,043 individuals aged ≥20 yr from urban and rural areas across 31 Indian States and Union Territories. In every fifth individual (n=19,370), venous blood glucose and lipids were measured. A body mass index (BMI) ≥25 kg/m2 was defined as being obese, and metabolic obesity was diagnosed if two risk factors, out of the following: high waist circumference, high blood pressure, elevated blood glucose, raised serum triglycerides, or low HDL cholesterol, were present. Four subgroups were identified: Metabolically Healthy Non-Obese (MHNO), Metabolically Healthy Obese (MHO), Metabolically Obese Non-Obese (MONO), and Metabolically Obese Obese (MOO). Results The prevalence of various obesity subtypes was as follows: MONO: 43.3 per cent [95% confidence interval (CI): 42.6-44%], MOO: 28.3 per cent (27.7-28.9%), MHNO: 26.6 per cent (26-27.2%), and MHO: 1.8 per cent (1.6-2%). MONO was more prevalent in rural areas [Rural vs. Urban: MONO: 46 per cent (45-46.9%) vs. 39.6 per cent (37.8-41.3%), P<0.001]. MOO showed the highest risk for T2D and CAD, while MONO showed the highest risk of CKD, especially among females. Interpretation & conclusions Individuals with MONO have a distinct phenotype with adverse metabolic consequences, highlighting the need to shift from body weight-focused approaches to broader strategies to identify and tackle non-communicable diseases (NCDs) in India.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"161 5","pages":"461-472"},"PeriodicalIF":2.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25259/IJMR_328_2025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background & objectives While obesity usually produces cardio-metabolic dysfunction, some obese individuals are metabolically healthy, and conversely, some nonobese individuals have significant metabolic dysfunction. This study aims to assess the national prevalence of various obesity subtypes and their association with type 2 diabetes (T2D), coronary artery disease (CAD), and chronic kidney disease (CKD) in the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Methods The ICMR-INDIAB study is a nationally representative cross-sectional survey of 1,13,043 individuals aged ≥20 yr from urban and rural areas across 31 Indian States and Union Territories. In every fifth individual (n=19,370), venous blood glucose and lipids were measured. A body mass index (BMI) ≥25 kg/m2 was defined as being obese, and metabolic obesity was diagnosed if two risk factors, out of the following: high waist circumference, high blood pressure, elevated blood glucose, raised serum triglycerides, or low HDL cholesterol, were present. Four subgroups were identified: Metabolically Healthy Non-Obese (MHNO), Metabolically Healthy Obese (MHO), Metabolically Obese Non-Obese (MONO), and Metabolically Obese Obese (MOO). Results The prevalence of various obesity subtypes was as follows: MONO: 43.3 per cent [95% confidence interval (CI): 42.6-44%], MOO: 28.3 per cent (27.7-28.9%), MHNO: 26.6 per cent (26-27.2%), and MHO: 1.8 per cent (1.6-2%). MONO was more prevalent in rural areas [Rural vs. Urban: MONO: 46 per cent (45-46.9%) vs. 39.6 per cent (37.8-41.3%), P<0.001]. MOO showed the highest risk for T2D and CAD, while MONO showed the highest risk of CKD, especially among females. Interpretation & conclusions Individuals with MONO have a distinct phenotype with adverse metabolic consequences, highlighting the need to shift from body weight-focused approaches to broader strategies to identify and tackle non-communicable diseases (NCDs) in India.

印度代谢性肥胖的高患病率:ICMR-INDIAB国家研究(ICMR-INDIAB-23)
背景与目的虽然肥胖通常会导致心脏代谢功能障碍,但一些肥胖者代谢健康,相反,一些非肥胖者有明显的代谢功能障碍。本研究旨在评估印度医学研究委员会印度糖尿病(ICMR-INDIAB)研究中各种肥胖亚型的全国患病率及其与2型糖尿病(T2D)、冠状动脉疾病(CAD)和慢性肾脏疾病(CKD)的关系。ICMR-INDIAB研究是一项具有全国代表性的横断面调查,来自31个印度邦和联邦属地的城市和农村地区,年龄≥20岁的113043人。在每五分之一的个体(n=19,370)中,测量静脉血血糖和血脂。体重指数(BMI)≥25kg /m2定义为肥胖,如果存在以下两个危险因素:高腰围、高血压、血糖升高、血清甘油三酯升高或低HDL胆固醇,则诊断为代谢性肥胖。确定了四个亚组:代谢健康非肥胖(MHNO)、代谢健康肥胖(MHO)、代谢肥胖非肥胖(MONO)和代谢肥胖肥胖(MOO)。结果各肥胖亚型患病率分别为:MONO: 43.3%[95%可信区间(CI): 42.6 ~ 44%], MOO: 28.3% (27.7 ~ 28.9%), MHNO: 26.6% (26 ~ 27.2%), MHO: 1.8%(1.6 ~ 2%)。MONO在农村地区更为普遍[农村vs.城市:MONO: 46% (45-46.9%) vs. 39.6% (37.8-41.3%), P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
2.40%
发文量
191
审稿时长
3-8 weeks
期刊介绍: The Indian Journal of Medical Research (IJMR) [ISSN 0971-5916] is one of the oldest medical Journals not only in India, but probably in Asia, as it started in the year 1913. The Journal was started as a quarterly (4 issues/year) in 1913 and made bimonthly (6 issues/year) in 1958. It became monthly (12 issues/year) in the year 1964.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信